Patients with treatment-resistant insomnia taking nightly prescription medications for sleep: A retrospective assessment of diagnostic and treatment variables

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 12, Issue 4, 2010, Pages

  Krakow, Barry ^a   Ulibarri, Victor A ^a   Romero, Edward A ^a  

^a Sleep and Human Health Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; ESCITALOPRAM; ESZOPICLONE; FLUOXETINE; FLURAZEPAM; HALOPERIDOL; LORAZEPAM; MOOD STABILIZER; OLANZAPINE; PAROXETINE; SERTRALINE; TEMAZEPAM; TRAZODONE; VENLAFAXINE; ZALEPLON; ZOLPIDEM;

ADL DISABILITY; ADULT; ANXIETY; APNEA HYPOPNEA INDEX; ARTICLE; BIPOLAR DISORDER; CLAUSTROPHOBIA; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE SEVERITY; DISSOCIATIVE DISORDER; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PANIC; POLYSOMNOGRAPHY; POSTTRAUMATIC STRESS DISORDER; PSYCHOTRAUMA; SCHIZOPHRENIA; SELF REPORT; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING;

EID: 78650562954     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.09m00873bro     Document Type: Article

References (43)

1. Ring D. Management of chronic insomnia in the elderly. Clin Excell Nurse Pract. 2001;5(1):13-16. PubMed
2. Szelenberger W, Soldatos C. Sleep disorders in psychiatric practice. World Psychiatry. 2005;4(3):186-190. PubMed
3. Maher MJ, Rego SA, Asnis GM. Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management. CNS Drugs. 2006;20(7):567-590. PubMed doi:10.2165/00023210-200620070-00003
4. Schwartz JR, Roth T. Shift work sleep disorder: burden of illness and approaches to management. Drugs. 2006;66(18):2357-2370. PubMed doi:10.2165/00003495-200666180-00007
5. Kupfer DJ, Reynolds CF III. Management of insomnia. N Engl J Med. 1997;336(5):341-346. PubMed doi:10.1056/NEJM199701303360506
6. Morin CM, Beaulieu-Bonneau S, LeBlanc M, et al. Self-help treatment for insomnia: a randomized controlled trial. Sleep. 2005;28(10):1319-1327. PubMed
7. Roehrs T, Papineau K, Rosenthal L, et al. Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood. Neuropsychopharmacology. 1999;20(3):279-286. PubMed doi:10.1016/S0893-133X(98)00068-2
8. Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol. 1995;63(1):79-89. PubMed doi:10.1037/0022-006X.63.1.79
9. Holbrook AM, Crowther R, Lotter A, et al. The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ. 2000;162(2):216-220. PubMed
10. Morin AK. Strategies for treating chronic insomnia. Am J Manag Care. 2006;12(suppl 8):S230-S245. PubMed
11. Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159(1):5-11. PubMed doi:10.1176/appi.ajp.159.1.5
12. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487-504. PubMed
13. Brooks D, Prothero W, Bouras N, et al. Trazodone: a comparison of single night-time and divided daily dosage regimens. Psychopharmacology (Berl). 1984;84(1):1-4. PubMed doi:10.1007/BF00432013
14. Becker PM. Treatment of sleep dysfunction and psychiatric disorders. Curr Treat Options Neurol. 2006;8(5):367-375. PubMed doi:10.1007/s11940-006-0026-6
15. US Food and Drug Administration. Ambien CR approval letter. 2005 http://www.fda.gov/cder/foi/appletter/2005/021774ltr.pdf. Accessed June 2008.
16. US Food and Drug Administration. Lunesta approval letter. 2008. http://www.fda.gov/cder/foi/appletter/2004/021476ltr.pdf. Accessed June 2008.
17. US Food and Drug Administration. Ambien. Highlights of prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019908s022lbl.pdf. Accessed July 2010.
18. US Food and Drug Administration. Lunesta (eszopiclone) tablets.http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm106688.htm. Accessed July 2010.
19. Botteman MF, Ozminkowski RJ, Wang S, et al. Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model. CNS Drugs. 2007;21(4):319-334. PubMed doi:10.2165/00023210-200721040-00005
20. Guilleminault C, Palombini L, Poyares D, et al. Chronic insomnia, premenopausal women and sleep disordered breathing, part 2: comparison of nondrug treatment trials in normal breathing and UARS post menopausal women complaining of chronic insomnia. J Psychosom Res. 2002;53(1):617-623. PubMed doi:10.1016/S0022-3999(02)00463-4
21. Krakow B, Melendrez D, Warner TD, et al. Signs and symptoms of sleep-disordered breathing in trauma survivors: a matched comparison with classic sleep apnea patients. J Nerv Ment Dis. 2006;194(6):433-439. PubMed doi:10.1097/01.nmd.0000221286.65021.e0
22. Krakow BJ, Melendrez DC, Johnston LG, et al. Sleep dynamic therapy for Cerro Grande fire evacuees with posttraumatic stress symptoms: a preliminary report. J Clin Psychiatry. 2002;63(8):673-684. PubMed
23. Krakow B, Melendrez D, Pedersen B, et al. Complex insomnia: insomnia and sleep-disordered breathing in a consecutive series of crime victims with nightmares and PTSD. Biol Psychiatry. 2001;49(11):948-953. PubMed doi:10.1016/S0006-3223(00)01087-8
24. Sivertsen B, Omvik S, Pallesen S, et al. Sleep and sleep disorders in chronic users of zopiclone and drug-free insomniacs. J Clin Sleep Med. 2009;5(4):349-354. PubMed
25. Krakow B, Melendrez D, Ferreira E, et al. Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest. 2001;120(6):1923-1929. PubMed doi:10.1378/chest.120.6.1923
26. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297-307. PubMed doi:10.1016/S1389-9457(00)00065-4
27. Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991;36(3):291-298. PubMed doi:10.1016/0165-1781(91)90027-M
28. Zallek SN, Redenius R, Fisk H, et al. A single question as a sleepiness screening tool. J Clin Sleep Med. 2008;4(2):143-148. PubMed
29. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, CA: Brain Information Service/Brain Research Institute; 1968.
30. American Academy of Sleep Medicine. International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
31. Hosselet J, Ayappa I, Norman RG, et al. Classification of sleep-disordered breathing. Am J Respir Crit Care Med. 2001;163(2):398-405. PubMed
32. Oberndorfer S, Saletu-Zyhlarz G, Saletu B. Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality. Neuropsychobiology. 2000;42(2):69-81. PubMed doi:10.1159/000026676
33. Riedel BW, Winfield CF, Lichstein KL. First night effect and reverse first night effect in older adults with primary insomnia: does anxiety play a role? Sleep Med. 2001;2(2):125-133. PubMed doi:10.1016/S1389-9457(00)00054-X
34. Sharpley AL, Cowen PJ. Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry. 1995;37(2):85-98. PubMed doi:10.1016/0006-3223(94)00135-P
35. Hedemark LL, Kronenberg RS. Flurazepam attenuates the arousal response to CO2 during sleep in normal subjects. Am Rev Respir Dis. 1983;128(6):980-983. PubMed
36. Lu B, Budhiraja R, Parthasarathy S. Sedating medications and undiagnosed obstructive sleep apnea: physician determinants and patient consequences. J Clin Sleep Med. 2005;1(4):367-371. PubMed
37. Krakow B, Melendrez D, Sisley B, et al. Nasal dilator strip therapy for chronic sleep maintenance insomnia: a case series. Sleep Breath. 2004;8(3):133-140. PubMed doi:10.1055/s-2004-834483
38. Krakow B, Melendrez D, Lee SA, et al. Refractory insomnia and sleep-disordered breathing: a pilot study. Sleep Breath. 2004;8(1):15-29. PubMed doi:10.1007/s11325-004-0015-5
39. Benetó A, Gomez-Siurana E, Rubio-Sanchez P. Comorbidity between sleep apnea and insomnia. Sleep Med Rev. 2009;13(4):287-293. PubMed doi:10.1016/j.smrv.2008.09.006
40. Meyer D, Leventhal H, Gutmann M. Common-sense models of illness: the example of hypertension. Health Psychol. 1985;4(2):115-135. PubMed doi:10.1037/0278-6133.4.2.115
41. Cooper C, Bebbington P, King M, et al. Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey. Acta Psychiatr Scand. 2007;116(1):47-53. PubMed doi:10.1111/j.1600-0447.2006.00974.x
42. Mitchell AJ. Adherence behaviour with psychotropic medication is a form of self-medication. Med Hypotheses. 2007;68(1):12-21. PubMed doi:10.1016/j.mehy.2006.07.005
43. Kramer M. Hypnotic medication in the treatment of chronic insomnia: non nocere! Doesn't anyone care? Sleep Med Rev. 2000;4(6):529-541. PubMed doi:10.1053/smrv.2000.0122